Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

LUCID DIAGNOSTICS INC.

(LUCD)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Lucid Diagnostics : Shares Drop in Nasdaq Trading Debut

10/14/2021 | 01:10pm EST


ę MT Newswires 2021
All news about LUCID DIAGNOSTICS INC.
12/02LUCID DIAGNOSTICS : PAVmed Subsidiary Lucid Diagnostics Launches EsoGuard Telemedicine Pro..
PU
12/02LUCID DIAGNOSTICS INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form..
AQ
12/01Lucid Diagnostics Launches EsoGuard Telemedicine Program in Partnership with UpScriptHe..
CI
11/23LUCID DIAGNOSTICS INC. Management's Discussion and Analysis of Financial Condition and..
AQ
11/17PAVmed's Q3 Adjusted Loss Widens
MT
11/16PAVmed and Lucid Provide Business Update and Preliminary Third Quarter 2021 Financial R..
BU
11/12LUCID DIAGNOSTICS INC. : Regulation FD Disclosure (form 8-K)
AQ
11/11Lucid Diagnostics Launches Next Phase of Lucid Test Centers
CI
11/08Canaccord Genuity Initiates Lucid Diagnostics at Buy Rating With $18 Price Target
MT
11/08BTIG Starts Lucid Diagnostics at Buy with $14 Price Target
MT
More news
Analyst Recommendations on LUCID DIAGNOSTICS INC.
More recommendations
Financials (USD)
Sales 2021 0,47 M - -
Net income 2021 -23,0 M - -
Net Debt 2021 - - -
P/E ratio 2021 -5,26x
Yield 2021 -
Capitalization 265 M 265 M -
Capi. / Sales 2021 567x
Capi. / Sales 2022 44,2x
Nbr of Employees -
Free-Float 19,5%
Chart LUCID DIAGNOSTICS INC.
Duration : Period :
Lucid Diagnostics Inc. Technical Analysis Chart | LUCD | US54948X1090 | MarketScreener
Technical analysis trends LUCID DIAGNOSTICS INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 4
Last Close Price 7,19 $
Average target price 17,50 $
Spread / Average Target 143%
EPS Revisions
Managers and Directors
Lishan Aklog Executive Chairman & Chief Executive Officer
Dennis M. McGrath Chief Financial Officer & Director
David F. Wurtman Chief Medical Officer
Suman M. Verma Chief Scientific Officer
Randy Brown Chief Operating Officer
Sector and Competitors
1st jan.Capi. (M$)
LUCID DIAGNOSTICS INC.0.00%265
MASIMO CORPORATION3.20%15 295
GETINGE AB95.11%11 152
PENUMBRA, INC.39.15%8 894
NOVOCURE LIMITED-47.37%8 519
IRAY TECHNOLOGY COMPANY LIMITED211.61%6 087